Global Small Nucleic Acid Therapies Market Growth (Status and Outlook) 2026-2032
The global Small Nucleic Acid Therapies market size is predicted to grow from US$ 13090 million in 2025 to US$ 16980 million in 2032; it is expected to grow at a CAGR of 3.9% from 2026 to 2032.
Small Nucleic Acid Therapies are a class of pharmaceuticals designed to treat various diseases by targeting specific genes or genetic processes within the human body. They are distinct from traditional small molecule drugs and instead rely on nucleic acids, which are the building blocks of genetic information. Nucleic acid drugs encompass various types of pharmaceuticals that use nucleic acids, such as DNA or RNA, as their active components to target specific genes or genetic processes.
United States market for Small Nucleic Acid Therapies is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Small Nucleic Acid Therapies is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Small Nucleic Acid Therapies is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Small Nucleic Acid Therapies players cover Sarepta Therapeutics, Ionis Pharmaceuticals, Alnylam, Biogen, Nippon Shinyaku, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?Small Nucleic Acid Therapies Industry Forecast? looks at past sales and reviews total world Small Nucleic Acid Therapies sales in 2025, providing a comprehensive analysis by region and market sector of projected Small Nucleic Acid Therapies sales for 2026 through 2032. With Small Nucleic Acid Therapies sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Small Nucleic Acid Therapies industry.
This Insight Report provides a comprehensive analysis of the global Small Nucleic Acid Therapies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Small Nucleic Acid Therapies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Small Nucleic Acid Therapies market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Small Nucleic Acid Therapies and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Small Nucleic Acid Therapies.
This report presents a comprehensive overview, market shares, and growth opportunities of Small Nucleic Acid Therapies market by product type, application, key players and key regions and countries.
Segmentation by Type:
Small Nucleic Acid Therapies are a class of pharmaceuticals designed to treat various diseases by targeting specific genes or genetic processes within the human body. They are distinct from traditional small molecule drugs and instead rely on nucleic acids, which are the building blocks of genetic information. Nucleic acid drugs encompass various types of pharmaceuticals that use nucleic acids, such as DNA or RNA, as their active components to target specific genes or genetic processes.
United States market for Small Nucleic Acid Therapies is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Small Nucleic Acid Therapies is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Small Nucleic Acid Therapies is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Small Nucleic Acid Therapies players cover Sarepta Therapeutics, Ionis Pharmaceuticals, Alnylam, Biogen, Nippon Shinyaku, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?Small Nucleic Acid Therapies Industry Forecast? looks at past sales and reviews total world Small Nucleic Acid Therapies sales in 2025, providing a comprehensive analysis by region and market sector of projected Small Nucleic Acid Therapies sales for 2026 through 2032. With Small Nucleic Acid Therapies sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Small Nucleic Acid Therapies industry.
This Insight Report provides a comprehensive analysis of the global Small Nucleic Acid Therapies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Small Nucleic Acid Therapies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Small Nucleic Acid Therapies market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Small Nucleic Acid Therapies and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Small Nucleic Acid Therapies.
This report presents a comprehensive overview, market shares, and growth opportunities of Small Nucleic Acid Therapies market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Antisense Oligonucleotides (ASO)
- siRNA
- mRNA
- Neuromuscular Diseases
- hATTR
- COVID-19
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sarepta Therapeutics
- Ionis Pharmaceuticals
- Alnylam
- Biogen
- Nippon Shinyaku
- Sobi
- Novartis
- BioNTech
- Pfizer
- Moderna Therapeutics
- Jazz Pharmaceuticals
- CureVac
- Regulus Therapeutics
- ProQR
- Secarna
- MiNA Therapeutics
- Sylentis
- Arrowhead
- Silence Therapeutics
- Dicerna
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Small Nucleic Acid Therapies Market Size (2021-2032)
2.1.2 Small Nucleic Acid Therapies Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Small Nucleic Acid Therapies by Country/Region (2021, 2025 & 2032)
2.2 Small Nucleic Acid Therapies Segment by Type
2.2.1 Antisense Oligonucleotides (ASO)
2.2.2 siRNA
2.2.3 mRNA
2.2.4 Small Nucleic Acid Therapies Market Size by Type
2.2.4.1 Small Nucleic Acid Therapies Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Small Nucleic Acid Therapies Market Size Market Share by Type (2021-2026)
2.3 Small Nucleic Acid Therapies Segment by Application
2.3.1 Neuromuscular Diseases
2.3.2 hATTR
2.3.3 COVID-19
2.3.4 Other
2.3.5 Small Nucleic Acid Therapies Market Size by Application
2.3.5.1 Small Nucleic Acid Therapies Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.5.2 Global Small Nucleic Acid Therapies Market Size Market Share by Application (2021-2026)
3 SMALL NUCLEIC ACID THERAPIES MARKET SIZE BY PLAYER
3.1 Small Nucleic Acid Therapies Market Size Market Share by Player
3.1.1 Global Small Nucleic Acid Therapies Revenue by Player (2021-2026)
3.1.2 Global Small Nucleic Acid Therapies Revenue Market Share by Player (2021-2026)
3.2 Global Small Nucleic Acid Therapies Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 SMALL NUCLEIC ACID THERAPIES BY REGION
4.1 Small Nucleic Acid Therapies Market Size by Region (2021-2026)
4.2 Global Small Nucleic Acid Therapies Annual Revenue by Country/Region (2021-2026)
4.3 Americas Small Nucleic Acid Therapies Market Size Growth (2021-2026)
4.4 APAC Small Nucleic Acid Therapies Market Size Growth (2021-2026)
4.5 Europe Small Nucleic Acid Therapies Market Size Growth (2021-2026)
4.6 Middle East & Africa Small Nucleic Acid Therapies Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Small Nucleic Acid Therapies Market Size by Country (2021-2026)
5.2 Americas Small Nucleic Acid Therapies Market Size by Type (2021-2026)
5.3 Americas Small Nucleic Acid Therapies Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Small Nucleic Acid Therapies Market Size by Region (2021-2026)
6.2 APAC Small Nucleic Acid Therapies Market Size by Type (2021-2026)
6.3 APAC Small Nucleic Acid Therapies Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Small Nucleic Acid Therapies Market Size by Country (2021-2026)
7.2 Europe Small Nucleic Acid Therapies Market Size by Type (2021-2026)
7.3 Europe Small Nucleic Acid Therapies Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Small Nucleic Acid Therapies by Region (2021-2026)
8.2 Middle East & Africa Small Nucleic Acid Therapies Market Size by Type (2021-2026)
8.3 Middle East & Africa Small Nucleic Acid Therapies Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL SMALL NUCLEIC ACID THERAPIES MARKET FORECAST
10.1 Global Small Nucleic Acid Therapies Forecast by Region (2027-2032)
10.1.1 Global Small Nucleic Acid Therapies Forecast by Region (2027-2032)
10.1.2 Americas Small Nucleic Acid Therapies Forecast
10.1.3 APAC Small Nucleic Acid Therapies Forecast
10.1.4 Europe Small Nucleic Acid Therapies Forecast
10.1.5 Middle East & Africa Small Nucleic Acid Therapies Forecast
10.2 Americas Small Nucleic Acid Therapies Forecast by Country (2027-2032)
10.2.1 United States Market Small Nucleic Acid Therapies Forecast
10.2.2 Canada Market Small Nucleic Acid Therapies Forecast
10.2.3 Mexico Market Small Nucleic Acid Therapies Forecast
10.2.4 Brazil Market Small Nucleic Acid Therapies Forecast
10.3 APAC Small Nucleic Acid Therapies Forecast by Region (2027-2032)
10.3.1 China Small Nucleic Acid Therapies Market Forecast
10.3.2 Japan Market Small Nucleic Acid Therapies Forecast
10.3.3 Korea Market Small Nucleic Acid Therapies Forecast
10.3.4 Southeast Asia Market Small Nucleic Acid Therapies Forecast
10.3.5 India Market Small Nucleic Acid Therapies Forecast
10.3.6 Australia Market Small Nucleic Acid Therapies Forecast
10.4 Europe Small Nucleic Acid Therapies Forecast by Country (2027-2032)
10.4.1 Germany Market Small Nucleic Acid Therapies Forecast
10.4.2 France Market Small Nucleic Acid Therapies Forecast
10.4.3 UK Market Small Nucleic Acid Therapies Forecast
10.4.4 Italy Market Small Nucleic Acid Therapies Forecast
10.4.5 Russia Market Small Nucleic Acid Therapies Forecast
10.5 Middle East & Africa Small Nucleic Acid Therapies Forecast by Region (2027-2032)
10.5.1 Egypt Market Small Nucleic Acid Therapies Forecast
10.5.2 South Africa Market Small Nucleic Acid Therapies Forecast
10.5.3 Israel Market Small Nucleic Acid Therapies Forecast
10.5.4 Turkey Market Small Nucleic Acid Therapies Forecast
10.6 Global Small Nucleic Acid Therapies Forecast by Type (2027-2032)
10.7 Global Small Nucleic Acid Therapies Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Small Nucleic Acid Therapies Forecast
11 KEY PLAYERS ANALYSIS
11.1 Sarepta Therapeutics
11.1.1 Sarepta Therapeutics Company Information
11.1.2 Sarepta Therapeutics Small Nucleic Acid Therapies Product Offered
11.1.3 Sarepta Therapeutics Small Nucleic Acid Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Sarepta Therapeutics Main Business Overview
11.1.5 Sarepta Therapeutics Latest Developments
11.2 Ionis Pharmaceuticals
11.2.1 Ionis Pharmaceuticals Company Information
11.2.2 Ionis Pharmaceuticals Small Nucleic Acid Therapies Product Offered
11.2.3 Ionis Pharmaceuticals Small Nucleic Acid Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Ionis Pharmaceuticals Main Business Overview
11.2.5 Ionis Pharmaceuticals Latest Developments
11.3 Alnylam
11.3.1 Alnylam Company Information
11.3.2 Alnylam Small Nucleic Acid Therapies Product Offered
11.3.3 Alnylam Small Nucleic Acid Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Alnylam Main Business Overview
11.3.5 Alnylam Latest Developments
11.4 Biogen
11.4.1 Biogen Company Information
11.4.2 Biogen Small Nucleic Acid Therapies Product Offered
11.4.3 Biogen Small Nucleic Acid Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Biogen Main Business Overview
11.4.5 Biogen Latest Developments
11.5 Nippon Shinyaku
11.5.1 Nippon Shinyaku Company Information
11.5.2 Nippon Shinyaku Small Nucleic Acid Therapies Product Offered
11.5.3 Nippon Shinyaku Small Nucleic Acid Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Nippon Shinyaku Main Business Overview
11.5.5 Nippon Shinyaku Latest Developments
11.6 Sobi
11.6.1 Sobi Company Information
11.6.2 Sobi Small Nucleic Acid Therapies Product Offered
11.6.3 Sobi Small Nucleic Acid Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Sobi Main Business Overview
11.6.5 Sobi Latest Developments
11.7 Novartis
11.7.1 Novartis Company Information
11.7.2 Novartis Small Nucleic Acid Therapies Product Offered
11.7.3 Novartis Small Nucleic Acid Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Novartis Main Business Overview
11.7.5 Novartis Latest Developments
11.8 BioNTech
11.8.1 BioNTech Company Information
11.8.2 BioNTech Small Nucleic Acid Therapies Product Offered
11.8.3 BioNTech Small Nucleic Acid Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 BioNTech Main Business Overview
11.8.5 BioNTech Latest Developments
11.9 Pfizer
11.9.1 Pfizer Company Information
11.9.2 Pfizer Small Nucleic Acid Therapies Product Offered
11.9.3 Pfizer Small Nucleic Acid Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Pfizer Main Business Overview
11.9.5 Pfizer Latest Developments
11.10 Moderna Therapeutics
11.10.1 Moderna Therapeutics Company Information
11.10.2 Moderna Therapeutics Small Nucleic Acid Therapies Product Offered
11.10.3 Moderna Therapeutics Small Nucleic Acid Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Moderna Therapeutics Main Business Overview
11.10.5 Moderna Therapeutics Latest Developments
11.11 Jazz Pharmaceuticals
11.11.1 Jazz Pharmaceuticals Company Information
11.11.2 Jazz Pharmaceuticals Small Nucleic Acid Therapies Product Offered
11.11.3 Jazz Pharmaceuticals Small Nucleic Acid Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Jazz Pharmaceuticals Main Business Overview
11.11.5 Jazz Pharmaceuticals Latest Developments
11.12 CureVac
11.12.1 CureVac Company Information
11.12.2 CureVac Small Nucleic Acid Therapies Product Offered
11.12.3 CureVac Small Nucleic Acid Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 CureVac Main Business Overview
11.12.5 CureVac Latest Developments
11.13 Regulus Therapeutics
11.13.1 Regulus Therapeutics Company Information
11.13.2 Regulus Therapeutics Small Nucleic Acid Therapies Product Offered
11.13.3 Regulus Therapeutics Small Nucleic Acid Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Regulus Therapeutics Main Business Overview
11.13.5 Regulus Therapeutics Latest Developments
11.14 ProQR
11.14.1 ProQR Company Information
11.14.2 ProQR Small Nucleic Acid Therapies Product Offered
11.14.3 ProQR Small Nucleic Acid Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 ProQR Main Business Overview
11.14.5 ProQR Latest Developments
11.15 Secarna
11.15.1 Secarna Company Information
11.15.2 Secarna Small Nucleic Acid Therapies Product Offered
11.15.3 Secarna Small Nucleic Acid Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Secarna Main Business Overview
11.15.5 Secarna Latest Developments
11.16 MiNA Therapeutics
11.16.1 MiNA Therapeutics Company Information
11.16.2 MiNA Therapeutics Small Nucleic Acid Therapies Product Offered
11.16.3 MiNA Therapeutics Small Nucleic Acid Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 MiNA Therapeutics Main Business Overview
11.16.5 MiNA Therapeutics Latest Developments
11.17 Sylentis
11.17.1 Sylentis Company Information
11.17.2 Sylentis Small Nucleic Acid Therapies Product Offered
11.17.3 Sylentis Small Nucleic Acid Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Sylentis Main Business Overview
11.17.5 Sylentis Latest Developments
11.18 Arrowhead
11.18.1 Arrowhead Company Information
11.18.2 Arrowhead Small Nucleic Acid Therapies Product Offered
11.18.3 Arrowhead Small Nucleic Acid Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Arrowhead Main Business Overview
11.18.5 Arrowhead Latest Developments
11.19 Silence Therapeutics
11.19.1 Silence Therapeutics Company Information
11.19.2 Silence Therapeutics Small Nucleic Acid Therapies Product Offered
11.19.3 Silence Therapeutics Small Nucleic Acid Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Silence Therapeutics Main Business Overview
11.19.5 Silence Therapeutics Latest Developments
11.20 Dicerna
11.20.1 Dicerna Company Information
11.20.2 Dicerna Small Nucleic Acid Therapies Product Offered
11.20.3 Dicerna Small Nucleic Acid Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Dicerna Main Business Overview
11.20.5 Dicerna Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Small Nucleic Acid Therapies Market Size (2021-2032)
2.1.2 Small Nucleic Acid Therapies Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Small Nucleic Acid Therapies by Country/Region (2021, 2025 & 2032)
2.2 Small Nucleic Acid Therapies Segment by Type
2.2.1 Antisense Oligonucleotides (ASO)
2.2.2 siRNA
2.2.3 mRNA
2.2.4 Small Nucleic Acid Therapies Market Size by Type
2.2.4.1 Small Nucleic Acid Therapies Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Small Nucleic Acid Therapies Market Size Market Share by Type (2021-2026)
2.3 Small Nucleic Acid Therapies Segment by Application
2.3.1 Neuromuscular Diseases
2.3.2 hATTR
2.3.3 COVID-19
2.3.4 Other
2.3.5 Small Nucleic Acid Therapies Market Size by Application
2.3.5.1 Small Nucleic Acid Therapies Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.5.2 Global Small Nucleic Acid Therapies Market Size Market Share by Application (2021-2026)
3 SMALL NUCLEIC ACID THERAPIES MARKET SIZE BY PLAYER
3.1 Small Nucleic Acid Therapies Market Size Market Share by Player
3.1.1 Global Small Nucleic Acid Therapies Revenue by Player (2021-2026)
3.1.2 Global Small Nucleic Acid Therapies Revenue Market Share by Player (2021-2026)
3.2 Global Small Nucleic Acid Therapies Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 SMALL NUCLEIC ACID THERAPIES BY REGION
4.1 Small Nucleic Acid Therapies Market Size by Region (2021-2026)
4.2 Global Small Nucleic Acid Therapies Annual Revenue by Country/Region (2021-2026)
4.3 Americas Small Nucleic Acid Therapies Market Size Growth (2021-2026)
4.4 APAC Small Nucleic Acid Therapies Market Size Growth (2021-2026)
4.5 Europe Small Nucleic Acid Therapies Market Size Growth (2021-2026)
4.6 Middle East & Africa Small Nucleic Acid Therapies Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Small Nucleic Acid Therapies Market Size by Country (2021-2026)
5.2 Americas Small Nucleic Acid Therapies Market Size by Type (2021-2026)
5.3 Americas Small Nucleic Acid Therapies Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Small Nucleic Acid Therapies Market Size by Region (2021-2026)
6.2 APAC Small Nucleic Acid Therapies Market Size by Type (2021-2026)
6.3 APAC Small Nucleic Acid Therapies Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Small Nucleic Acid Therapies Market Size by Country (2021-2026)
7.2 Europe Small Nucleic Acid Therapies Market Size by Type (2021-2026)
7.3 Europe Small Nucleic Acid Therapies Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Small Nucleic Acid Therapies by Region (2021-2026)
8.2 Middle East & Africa Small Nucleic Acid Therapies Market Size by Type (2021-2026)
8.3 Middle East & Africa Small Nucleic Acid Therapies Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL SMALL NUCLEIC ACID THERAPIES MARKET FORECAST
10.1 Global Small Nucleic Acid Therapies Forecast by Region (2027-2032)
10.1.1 Global Small Nucleic Acid Therapies Forecast by Region (2027-2032)
10.1.2 Americas Small Nucleic Acid Therapies Forecast
10.1.3 APAC Small Nucleic Acid Therapies Forecast
10.1.4 Europe Small Nucleic Acid Therapies Forecast
10.1.5 Middle East & Africa Small Nucleic Acid Therapies Forecast
10.2 Americas Small Nucleic Acid Therapies Forecast by Country (2027-2032)
10.2.1 United States Market Small Nucleic Acid Therapies Forecast
10.2.2 Canada Market Small Nucleic Acid Therapies Forecast
10.2.3 Mexico Market Small Nucleic Acid Therapies Forecast
10.2.4 Brazil Market Small Nucleic Acid Therapies Forecast
10.3 APAC Small Nucleic Acid Therapies Forecast by Region (2027-2032)
10.3.1 China Small Nucleic Acid Therapies Market Forecast
10.3.2 Japan Market Small Nucleic Acid Therapies Forecast
10.3.3 Korea Market Small Nucleic Acid Therapies Forecast
10.3.4 Southeast Asia Market Small Nucleic Acid Therapies Forecast
10.3.5 India Market Small Nucleic Acid Therapies Forecast
10.3.6 Australia Market Small Nucleic Acid Therapies Forecast
10.4 Europe Small Nucleic Acid Therapies Forecast by Country (2027-2032)
10.4.1 Germany Market Small Nucleic Acid Therapies Forecast
10.4.2 France Market Small Nucleic Acid Therapies Forecast
10.4.3 UK Market Small Nucleic Acid Therapies Forecast
10.4.4 Italy Market Small Nucleic Acid Therapies Forecast
10.4.5 Russia Market Small Nucleic Acid Therapies Forecast
10.5 Middle East & Africa Small Nucleic Acid Therapies Forecast by Region (2027-2032)
10.5.1 Egypt Market Small Nucleic Acid Therapies Forecast
10.5.2 South Africa Market Small Nucleic Acid Therapies Forecast
10.5.3 Israel Market Small Nucleic Acid Therapies Forecast
10.5.4 Turkey Market Small Nucleic Acid Therapies Forecast
10.6 Global Small Nucleic Acid Therapies Forecast by Type (2027-2032)
10.7 Global Small Nucleic Acid Therapies Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Small Nucleic Acid Therapies Forecast
11 KEY PLAYERS ANALYSIS
11.1 Sarepta Therapeutics
11.1.1 Sarepta Therapeutics Company Information
11.1.2 Sarepta Therapeutics Small Nucleic Acid Therapies Product Offered
11.1.3 Sarepta Therapeutics Small Nucleic Acid Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Sarepta Therapeutics Main Business Overview
11.1.5 Sarepta Therapeutics Latest Developments
11.2 Ionis Pharmaceuticals
11.2.1 Ionis Pharmaceuticals Company Information
11.2.2 Ionis Pharmaceuticals Small Nucleic Acid Therapies Product Offered
11.2.3 Ionis Pharmaceuticals Small Nucleic Acid Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Ionis Pharmaceuticals Main Business Overview
11.2.5 Ionis Pharmaceuticals Latest Developments
11.3 Alnylam
11.3.1 Alnylam Company Information
11.3.2 Alnylam Small Nucleic Acid Therapies Product Offered
11.3.3 Alnylam Small Nucleic Acid Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Alnylam Main Business Overview
11.3.5 Alnylam Latest Developments
11.4 Biogen
11.4.1 Biogen Company Information
11.4.2 Biogen Small Nucleic Acid Therapies Product Offered
11.4.3 Biogen Small Nucleic Acid Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Biogen Main Business Overview
11.4.5 Biogen Latest Developments
11.5 Nippon Shinyaku
11.5.1 Nippon Shinyaku Company Information
11.5.2 Nippon Shinyaku Small Nucleic Acid Therapies Product Offered
11.5.3 Nippon Shinyaku Small Nucleic Acid Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Nippon Shinyaku Main Business Overview
11.5.5 Nippon Shinyaku Latest Developments
11.6 Sobi
11.6.1 Sobi Company Information
11.6.2 Sobi Small Nucleic Acid Therapies Product Offered
11.6.3 Sobi Small Nucleic Acid Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Sobi Main Business Overview
11.6.5 Sobi Latest Developments
11.7 Novartis
11.7.1 Novartis Company Information
11.7.2 Novartis Small Nucleic Acid Therapies Product Offered
11.7.3 Novartis Small Nucleic Acid Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Novartis Main Business Overview
11.7.5 Novartis Latest Developments
11.8 BioNTech
11.8.1 BioNTech Company Information
11.8.2 BioNTech Small Nucleic Acid Therapies Product Offered
11.8.3 BioNTech Small Nucleic Acid Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 BioNTech Main Business Overview
11.8.5 BioNTech Latest Developments
11.9 Pfizer
11.9.1 Pfizer Company Information
11.9.2 Pfizer Small Nucleic Acid Therapies Product Offered
11.9.3 Pfizer Small Nucleic Acid Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Pfizer Main Business Overview
11.9.5 Pfizer Latest Developments
11.10 Moderna Therapeutics
11.10.1 Moderna Therapeutics Company Information
11.10.2 Moderna Therapeutics Small Nucleic Acid Therapies Product Offered
11.10.3 Moderna Therapeutics Small Nucleic Acid Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Moderna Therapeutics Main Business Overview
11.10.5 Moderna Therapeutics Latest Developments
11.11 Jazz Pharmaceuticals
11.11.1 Jazz Pharmaceuticals Company Information
11.11.2 Jazz Pharmaceuticals Small Nucleic Acid Therapies Product Offered
11.11.3 Jazz Pharmaceuticals Small Nucleic Acid Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Jazz Pharmaceuticals Main Business Overview
11.11.5 Jazz Pharmaceuticals Latest Developments
11.12 CureVac
11.12.1 CureVac Company Information
11.12.2 CureVac Small Nucleic Acid Therapies Product Offered
11.12.3 CureVac Small Nucleic Acid Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 CureVac Main Business Overview
11.12.5 CureVac Latest Developments
11.13 Regulus Therapeutics
11.13.1 Regulus Therapeutics Company Information
11.13.2 Regulus Therapeutics Small Nucleic Acid Therapies Product Offered
11.13.3 Regulus Therapeutics Small Nucleic Acid Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Regulus Therapeutics Main Business Overview
11.13.5 Regulus Therapeutics Latest Developments
11.14 ProQR
11.14.1 ProQR Company Information
11.14.2 ProQR Small Nucleic Acid Therapies Product Offered
11.14.3 ProQR Small Nucleic Acid Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 ProQR Main Business Overview
11.14.5 ProQR Latest Developments
11.15 Secarna
11.15.1 Secarna Company Information
11.15.2 Secarna Small Nucleic Acid Therapies Product Offered
11.15.3 Secarna Small Nucleic Acid Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Secarna Main Business Overview
11.15.5 Secarna Latest Developments
11.16 MiNA Therapeutics
11.16.1 MiNA Therapeutics Company Information
11.16.2 MiNA Therapeutics Small Nucleic Acid Therapies Product Offered
11.16.3 MiNA Therapeutics Small Nucleic Acid Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 MiNA Therapeutics Main Business Overview
11.16.5 MiNA Therapeutics Latest Developments
11.17 Sylentis
11.17.1 Sylentis Company Information
11.17.2 Sylentis Small Nucleic Acid Therapies Product Offered
11.17.3 Sylentis Small Nucleic Acid Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Sylentis Main Business Overview
11.17.5 Sylentis Latest Developments
11.18 Arrowhead
11.18.1 Arrowhead Company Information
11.18.2 Arrowhead Small Nucleic Acid Therapies Product Offered
11.18.3 Arrowhead Small Nucleic Acid Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Arrowhead Main Business Overview
11.18.5 Arrowhead Latest Developments
11.19 Silence Therapeutics
11.19.1 Silence Therapeutics Company Information
11.19.2 Silence Therapeutics Small Nucleic Acid Therapies Product Offered
11.19.3 Silence Therapeutics Small Nucleic Acid Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Silence Therapeutics Main Business Overview
11.19.5 Silence Therapeutics Latest Developments
11.20 Dicerna
11.20.1 Dicerna Company Information
11.20.2 Dicerna Small Nucleic Acid Therapies Product Offered
11.20.3 Dicerna Small Nucleic Acid Therapies Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Dicerna Main Business Overview
11.20.5 Dicerna Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Small Nucleic Acid Therapies Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Small Nucleic Acid Therapies Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Antisense Oligonucleotides (ASO)
Table 4. Major Players of siRNA
Table 5. Major Players of mRNA
Table 6. Small Nucleic Acid Therapies Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Small Nucleic Acid Therapies Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Small Nucleic Acid Therapies Market Size Market Share by Type (2021-2026)
Table 9. Small Nucleic Acid Therapies Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Small Nucleic Acid Therapies Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Small Nucleic Acid Therapies Market Size Market Share by Application (2021-2026)
Table 12. Global Small Nucleic Acid Therapies Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Small Nucleic Acid Therapies Revenue Market Share by Player (2021-2026)
Table 14. Small Nucleic Acid Therapies Key Players Head office and Products Offered
Table 15. Small Nucleic Acid Therapies Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Small Nucleic Acid Therapies Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Small Nucleic Acid Therapies Market Size Market Share by Region (2021-2026)
Table 20. Global Small Nucleic Acid Therapies Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Small Nucleic Acid Therapies Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Small Nucleic Acid Therapies Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Small Nucleic Acid Therapies Market Size Market Share by Country (2021-2026)
Table 24. Americas Small Nucleic Acid Therapies Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Small Nucleic Acid Therapies Market Size Market Share by Type (2021-2026)
Table 26. Americas Small Nucleic Acid Therapies Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Small Nucleic Acid Therapies Market Size Market Share by Application (2021-2026)
Table 28. APAC Small Nucleic Acid Therapies Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Small Nucleic Acid Therapies Market Size Market Share by Region (2021-2026)
Table 30. APAC Small Nucleic Acid Therapies Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Small Nucleic Acid Therapies Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Small Nucleic Acid Therapies Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Small Nucleic Acid Therapies Market Size Market Share by Country (2021-2026)
Table 34. Europe Small Nucleic Acid Therapies Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Small Nucleic Acid Therapies Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Small Nucleic Acid Therapies Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Small Nucleic Acid Therapies Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Small Nucleic Acid Therapies Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Small Nucleic Acid Therapies
Table 40. Key Market Challenges & Risks of Small Nucleic Acid Therapies
Table 41. Key Industry Trends of Small Nucleic Acid Therapies
Table 42. Global Small Nucleic Acid Therapies Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Small Nucleic Acid Therapies Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Small Nucleic Acid Therapies Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Small Nucleic Acid Therapies Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Sarepta Therapeutics Details, Company Type, Small Nucleic Acid Therapies Area Served and Its Competitors
Table 47. Sarepta Therapeutics Small Nucleic Acid Therapies Product Offered
Table 48. Sarepta Therapeutics Small Nucleic Acid Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Sarepta Therapeutics Main Business
Table 50. Sarepta Therapeutics Latest Developments
Table 51. Ionis Pharmaceuticals Details, Company Type, Small Nucleic Acid Therapies Area Served and Its Competitors
Table 52. Ionis Pharmaceuticals Small Nucleic Acid Therapies Product Offered
Table 53. Ionis Pharmaceuticals Small Nucleic Acid Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Ionis Pharmaceuticals Main Business
Table 55. Ionis Pharmaceuticals Latest Developments
Table 56. Alnylam Details, Company Type, Small Nucleic Acid Therapies Area Served and Its Competitors
Table 57. Alnylam Small Nucleic Acid Therapies Product Offered
Table 58. Alnylam Small Nucleic Acid Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Alnylam Main Business
Table 60. Alnylam Latest Developments
Table 61. Biogen Details, Company Type, Small Nucleic Acid Therapies Area Served and Its Competitors
Table 62. Biogen Small Nucleic Acid Therapies Product Offered
Table 63. Biogen Small Nucleic Acid Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Biogen Main Business
Table 65. Biogen Latest Developments
Table 66. Nippon Shinyaku Details, Company Type, Small Nucleic Acid Therapies Area Served and Its Competitors
Table 67. Nippon Shinyaku Small Nucleic Acid Therapies Product Offered
Table 68. Nippon Shinyaku Small Nucleic Acid Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Nippon Shinyaku Main Business
Table 70. Nippon Shinyaku Latest Developments
Table 71. Sobi Details, Company Type, Small Nucleic Acid Therapies Area Served and Its Competitors
Table 72. Sobi Small Nucleic Acid Therapies Product Offered
Table 73. Sobi Small Nucleic Acid Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Sobi Main Business
Table 75. Sobi Latest Developments
Table 76. Novartis Details, Company Type, Small Nucleic Acid Therapies Area Served and Its Competitors
Table 77. Novartis Small Nucleic Acid Therapies Product Offered
Table 78. Novartis Small Nucleic Acid Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Novartis Main Business
Table 80. Novartis Latest Developments
Table 81. BioNTech Details, Company Type, Small Nucleic Acid Therapies Area Served and Its Competitors
Table 82. BioNTech Small Nucleic Acid Therapies Product Offered
Table 83. BioNTech Small Nucleic Acid Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. BioNTech Main Business
Table 85. BioNTech Latest Developments
Table 86. Pfizer Details, Company Type, Small Nucleic Acid Therapies Area Served and Its Competitors
Table 87. Pfizer Small Nucleic Acid Therapies Product Offered
Table 88. Pfizer Small Nucleic Acid Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Pfizer Main Business
Table 90. Pfizer Latest Developments
Table 91. Moderna Therapeutics Details, Company Type, Small Nucleic Acid Therapies Area Served and Its Competitors
Table 92. Moderna Therapeutics Small Nucleic Acid Therapies Product Offered
Table 93. Moderna Therapeutics Small Nucleic Acid Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Moderna Therapeutics Main Business
Table 95. Moderna Therapeutics Latest Developments
Table 96. Jazz Pharmaceuticals Details, Company Type, Small Nucleic Acid Therapies Area Served and Its Competitors
Table 97. Jazz Pharmaceuticals Small Nucleic Acid Therapies Product Offered
Table 98. Jazz Pharmaceuticals Small Nucleic Acid Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Jazz Pharmaceuticals Main Business
Table 100. Jazz Pharmaceuticals Latest Developments
Table 101. CureVac Details, Company Type, Small Nucleic Acid Therapies Area Served and Its Competitors
Table 102. CureVac Small Nucleic Acid Therapies Product Offered
Table 103. CureVac Small Nucleic Acid Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. CureVac Main Business
Table 105. CureVac Latest Developments
Table 106. Regulus Therapeutics Details, Company Type, Small Nucleic Acid Therapies Area Served and Its Competitors
Table 107. Regulus Therapeutics Small Nucleic Acid Therapies Product Offered
Table 108. Regulus Therapeutics Small Nucleic Acid Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. Regulus Therapeutics Main Business
Table 110. Regulus Therapeutics Latest Developments
Table 111. ProQR Details, Company Type, Small Nucleic Acid Therapies Area Served and Its Competitors
Table 112. ProQR Small Nucleic Acid Therapies Product Offered
Table 113. ProQR Small Nucleic Acid Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. ProQR Main Business
Table 115. ProQR Latest Developments
Table 116. Secarna Details, Company Type, Small Nucleic Acid Therapies Area Served and Its Competitors
Table 117. Secarna Small Nucleic Acid Therapies Product Offered
Table 118. Secarna Small Nucleic Acid Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. Secarna Main Business
Table 120. Secarna Latest Developments
Table 121. MiNA Therapeutics Details, Company Type, Small Nucleic Acid Therapies Area Served and Its Competitors
Table 122. MiNA Therapeutics Small Nucleic Acid Therapies Product Offered
Table 123. MiNA Therapeutics Small Nucleic Acid Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. MiNA Therapeutics Main Business
Table 125. MiNA Therapeutics Latest Developments
Table 126. Sylentis Details, Company Type, Small Nucleic Acid Therapies Area Served and Its Competitors
Table 127. Sylentis Small Nucleic Acid Therapies Product Offered
Table 128. Sylentis Small Nucleic Acid Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 129. Sylentis Main Business
Table 130. Sylentis Latest Developments
Table 131. Arrowhead Details, Company Type, Small Nucleic Acid Therapies Area Served and Its Competitors
Table 132. Arrowhead Small Nucleic Acid Therapies Product Offered
Table 133. Arrowhead Small Nucleic Acid Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 134. Arrowhead Main Business
Table 135. Arrowhead Latest Developments
Table 136. Silence Therapeutics Details, Company Type, Small Nucleic Acid Therapies Area Served and Its Competitors
Table 137. Silence Therapeutics Small Nucleic Acid Therapies Product Offered
Table 138. Silence Therapeutics Small Nucleic Acid Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 139. Silence Therapeutics Main Business
Table 140. Silence Therapeutics Latest Developments
Table 141. Dicerna Details, Company Type, Small Nucleic Acid Therapies Area Served and Its Competitors
Table 142. Dicerna Small Nucleic Acid Therapies Product Offered
Table 143. Dicerna Small Nucleic Acid Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 144. Dicerna Main Business
Table 145. Dicerna Latest Developments
Table 1. Small Nucleic Acid Therapies Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Small Nucleic Acid Therapies Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Antisense Oligonucleotides (ASO)
Table 4. Major Players of siRNA
Table 5. Major Players of mRNA
Table 6. Small Nucleic Acid Therapies Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Small Nucleic Acid Therapies Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Small Nucleic Acid Therapies Market Size Market Share by Type (2021-2026)
Table 9. Small Nucleic Acid Therapies Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Small Nucleic Acid Therapies Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Small Nucleic Acid Therapies Market Size Market Share by Application (2021-2026)
Table 12. Global Small Nucleic Acid Therapies Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Small Nucleic Acid Therapies Revenue Market Share by Player (2021-2026)
Table 14. Small Nucleic Acid Therapies Key Players Head office and Products Offered
Table 15. Small Nucleic Acid Therapies Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Small Nucleic Acid Therapies Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Small Nucleic Acid Therapies Market Size Market Share by Region (2021-2026)
Table 20. Global Small Nucleic Acid Therapies Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Small Nucleic Acid Therapies Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Small Nucleic Acid Therapies Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Small Nucleic Acid Therapies Market Size Market Share by Country (2021-2026)
Table 24. Americas Small Nucleic Acid Therapies Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Small Nucleic Acid Therapies Market Size Market Share by Type (2021-2026)
Table 26. Americas Small Nucleic Acid Therapies Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Small Nucleic Acid Therapies Market Size Market Share by Application (2021-2026)
Table 28. APAC Small Nucleic Acid Therapies Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Small Nucleic Acid Therapies Market Size Market Share by Region (2021-2026)
Table 30. APAC Small Nucleic Acid Therapies Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Small Nucleic Acid Therapies Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Small Nucleic Acid Therapies Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Small Nucleic Acid Therapies Market Size Market Share by Country (2021-2026)
Table 34. Europe Small Nucleic Acid Therapies Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Small Nucleic Acid Therapies Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Small Nucleic Acid Therapies Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Small Nucleic Acid Therapies Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Small Nucleic Acid Therapies Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Small Nucleic Acid Therapies
Table 40. Key Market Challenges & Risks of Small Nucleic Acid Therapies
Table 41. Key Industry Trends of Small Nucleic Acid Therapies
Table 42. Global Small Nucleic Acid Therapies Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Small Nucleic Acid Therapies Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Small Nucleic Acid Therapies Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Small Nucleic Acid Therapies Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Sarepta Therapeutics Details, Company Type, Small Nucleic Acid Therapies Area Served and Its Competitors
Table 47. Sarepta Therapeutics Small Nucleic Acid Therapies Product Offered
Table 48. Sarepta Therapeutics Small Nucleic Acid Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Sarepta Therapeutics Main Business
Table 50. Sarepta Therapeutics Latest Developments
Table 51. Ionis Pharmaceuticals Details, Company Type, Small Nucleic Acid Therapies Area Served and Its Competitors
Table 52. Ionis Pharmaceuticals Small Nucleic Acid Therapies Product Offered
Table 53. Ionis Pharmaceuticals Small Nucleic Acid Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Ionis Pharmaceuticals Main Business
Table 55. Ionis Pharmaceuticals Latest Developments
Table 56. Alnylam Details, Company Type, Small Nucleic Acid Therapies Area Served and Its Competitors
Table 57. Alnylam Small Nucleic Acid Therapies Product Offered
Table 58. Alnylam Small Nucleic Acid Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Alnylam Main Business
Table 60. Alnylam Latest Developments
Table 61. Biogen Details, Company Type, Small Nucleic Acid Therapies Area Served and Its Competitors
Table 62. Biogen Small Nucleic Acid Therapies Product Offered
Table 63. Biogen Small Nucleic Acid Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Biogen Main Business
Table 65. Biogen Latest Developments
Table 66. Nippon Shinyaku Details, Company Type, Small Nucleic Acid Therapies Area Served and Its Competitors
Table 67. Nippon Shinyaku Small Nucleic Acid Therapies Product Offered
Table 68. Nippon Shinyaku Small Nucleic Acid Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Nippon Shinyaku Main Business
Table 70. Nippon Shinyaku Latest Developments
Table 71. Sobi Details, Company Type, Small Nucleic Acid Therapies Area Served and Its Competitors
Table 72. Sobi Small Nucleic Acid Therapies Product Offered
Table 73. Sobi Small Nucleic Acid Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Sobi Main Business
Table 75. Sobi Latest Developments
Table 76. Novartis Details, Company Type, Small Nucleic Acid Therapies Area Served and Its Competitors
Table 77. Novartis Small Nucleic Acid Therapies Product Offered
Table 78. Novartis Small Nucleic Acid Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Novartis Main Business
Table 80. Novartis Latest Developments
Table 81. BioNTech Details, Company Type, Small Nucleic Acid Therapies Area Served and Its Competitors
Table 82. BioNTech Small Nucleic Acid Therapies Product Offered
Table 83. BioNTech Small Nucleic Acid Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. BioNTech Main Business
Table 85. BioNTech Latest Developments
Table 86. Pfizer Details, Company Type, Small Nucleic Acid Therapies Area Served and Its Competitors
Table 87. Pfizer Small Nucleic Acid Therapies Product Offered
Table 88. Pfizer Small Nucleic Acid Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Pfizer Main Business
Table 90. Pfizer Latest Developments
Table 91. Moderna Therapeutics Details, Company Type, Small Nucleic Acid Therapies Area Served and Its Competitors
Table 92. Moderna Therapeutics Small Nucleic Acid Therapies Product Offered
Table 93. Moderna Therapeutics Small Nucleic Acid Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Moderna Therapeutics Main Business
Table 95. Moderna Therapeutics Latest Developments
Table 96. Jazz Pharmaceuticals Details, Company Type, Small Nucleic Acid Therapies Area Served and Its Competitors
Table 97. Jazz Pharmaceuticals Small Nucleic Acid Therapies Product Offered
Table 98. Jazz Pharmaceuticals Small Nucleic Acid Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Jazz Pharmaceuticals Main Business
Table 100. Jazz Pharmaceuticals Latest Developments
Table 101. CureVac Details, Company Type, Small Nucleic Acid Therapies Area Served and Its Competitors
Table 102. CureVac Small Nucleic Acid Therapies Product Offered
Table 103. CureVac Small Nucleic Acid Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. CureVac Main Business
Table 105. CureVac Latest Developments
Table 106. Regulus Therapeutics Details, Company Type, Small Nucleic Acid Therapies Area Served and Its Competitors
Table 107. Regulus Therapeutics Small Nucleic Acid Therapies Product Offered
Table 108. Regulus Therapeutics Small Nucleic Acid Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. Regulus Therapeutics Main Business
Table 110. Regulus Therapeutics Latest Developments
Table 111. ProQR Details, Company Type, Small Nucleic Acid Therapies Area Served and Its Competitors
Table 112. ProQR Small Nucleic Acid Therapies Product Offered
Table 113. ProQR Small Nucleic Acid Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. ProQR Main Business
Table 115. ProQR Latest Developments
Table 116. Secarna Details, Company Type, Small Nucleic Acid Therapies Area Served and Its Competitors
Table 117. Secarna Small Nucleic Acid Therapies Product Offered
Table 118. Secarna Small Nucleic Acid Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. Secarna Main Business
Table 120. Secarna Latest Developments
Table 121. MiNA Therapeutics Details, Company Type, Small Nucleic Acid Therapies Area Served and Its Competitors
Table 122. MiNA Therapeutics Small Nucleic Acid Therapies Product Offered
Table 123. MiNA Therapeutics Small Nucleic Acid Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. MiNA Therapeutics Main Business
Table 125. MiNA Therapeutics Latest Developments
Table 126. Sylentis Details, Company Type, Small Nucleic Acid Therapies Area Served and Its Competitors
Table 127. Sylentis Small Nucleic Acid Therapies Product Offered
Table 128. Sylentis Small Nucleic Acid Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 129. Sylentis Main Business
Table 130. Sylentis Latest Developments
Table 131. Arrowhead Details, Company Type, Small Nucleic Acid Therapies Area Served and Its Competitors
Table 132. Arrowhead Small Nucleic Acid Therapies Product Offered
Table 133. Arrowhead Small Nucleic Acid Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 134. Arrowhead Main Business
Table 135. Arrowhead Latest Developments
Table 136. Silence Therapeutics Details, Company Type, Small Nucleic Acid Therapies Area Served and Its Competitors
Table 137. Silence Therapeutics Small Nucleic Acid Therapies Product Offered
Table 138. Silence Therapeutics Small Nucleic Acid Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 139. Silence Therapeutics Main Business
Table 140. Silence Therapeutics Latest Developments
Table 141. Dicerna Details, Company Type, Small Nucleic Acid Therapies Area Served and Its Competitors
Table 142. Dicerna Small Nucleic Acid Therapies Product Offered
Table 143. Dicerna Small Nucleic Acid Therapies Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 144. Dicerna Main Business
Table 145. Dicerna Latest Developments
LIST OF FIGURES
Figure 1. Small Nucleic Acid Therapies Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Small Nucleic Acid Therapies Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Small Nucleic Acid Therapies Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Small Nucleic Acid Therapies Sales Market Share by Country/Region (2025)
Figure 8. Small Nucleic Acid Therapies Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Small Nucleic Acid Therapies Market Size Market Share by Type in 2025
Figure 10. Small Nucleic Acid Therapies in Neuromuscular Diseases
Figure 11. Global Small Nucleic Acid Therapies Market: Neuromuscular Diseases (2021-2026) & ($ millions)
Figure 12. Small Nucleic Acid Therapies in hATTR
Figure 13. Global Small Nucleic Acid Therapies Market: hATTR (2021-2026) & ($ millions)
Figure 14. Small Nucleic Acid Therapies in COVID-19
Figure 15. Global Small Nucleic Acid Therapies Market: COVID-19 (2021-2026) & ($ millions)
Figure 16. Small Nucleic Acid Therapies in Other
Figure 17. Global Small Nucleic Acid Therapies Market: Other (2021-2026) & ($ millions)
Figure 18. Global Small Nucleic Acid Therapies Market Size Market Share by Application in 2025
Figure 19. Global Small Nucleic Acid Therapies Revenue Market Share by Player in 2025
Figure 20. Global Small Nucleic Acid Therapies Market Size Market Share by Region (2021-2026)
Figure 21. Americas Small Nucleic Acid Therapies Market Size 2021-2026 ($ millions)
Figure 22. APAC Small Nucleic Acid Therapies Market Size 2021-2026 ($ millions)
Figure 23. Europe Small Nucleic Acid Therapies Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Small Nucleic Acid Therapies Market Size 2021-2026 ($ millions)
Figure 25. Americas Small Nucleic Acid Therapies Value Market Share by Country in 2025
Figure 26. United States Small Nucleic Acid Therapies Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Small Nucleic Acid Therapies Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Small Nucleic Acid Therapies Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Small Nucleic Acid Therapies Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Small Nucleic Acid Therapies Market Size Market Share by Region in 2025
Figure 31. APAC Small Nucleic Acid Therapies Market Size Market Share by Type (2021-2026)
Figure 32. APAC Small Nucleic Acid Therapies Market Size Market Share by Application (2021-2026)
Figure 33. China Small Nucleic Acid Therapies Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Small Nucleic Acid Therapies Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Small Nucleic Acid Therapies Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Small Nucleic Acid Therapies Market Size Growth 2021-2026 ($ millions)
Figure 37. India Small Nucleic Acid Therapies Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Small Nucleic Acid Therapies Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Small Nucleic Acid Therapies Market Size Market Share by Country in 2025
Figure 40. Europe Small Nucleic Acid Therapies Market Size Market Share by Type (2021-2026)
Figure 41. Europe Small Nucleic Acid Therapies Market Size Market Share by Application (2021-2026)
Figure 42. Germany Small Nucleic Acid Therapies Market Size Growth 2021-2026 ($ millions)
Figure 43. France Small Nucleic Acid Therapies Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Small Nucleic Acid Therapies Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Small Nucleic Acid Therapies Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Small Nucleic Acid Therapies Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Small Nucleic Acid Therapies Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Small Nucleic Acid Therapies Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Small Nucleic Acid Therapies Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Small Nucleic Acid Therapies Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Small Nucleic Acid Therapies Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Small Nucleic Acid Therapies Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Small Nucleic Acid Therapies Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Small Nucleic Acid Therapies Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Small Nucleic Acid Therapies Market Size 2027-2032 ($ millions)
Figure 56. APAC Small Nucleic Acid Therapies Market Size 2027-2032 ($ millions)
Figure 57. Europe Small Nucleic Acid Therapies Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Small Nucleic Acid Therapies Market Size 2027-2032 ($ millions)
Figure 59. United States Small Nucleic Acid Therapies Market Size 2027-2032 ($ millions)
Figure 60. Canada Small Nucleic Acid Therapies Market Size 2027-2032 ($ millions)
Figure 61. Mexico Small Nucleic Acid Therapies Market Size 2027-2032 ($ millions)
Figure 62. Brazil Small Nucleic Acid Therapies Market Size 2027-2032 ($ millions)
Figure 63. China Small Nucleic Acid Therapies Market Size 2027-2032 ($ millions)
Figure 64. Japan Small Nucleic Acid Therapies Market Size 2027-2032 ($ millions)
Figure 65. Korea Small Nucleic Acid Therapies Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Small Nucleic Acid Therapies Market Size 2027-2032 ($ millions)
Figure 67. India Small Nucleic Acid Therapies Market Size 2027-2032 ($ millions)
Figure 68. Australia Small Nucleic Acid Therapies Market Size 2027-2032 ($ millions)
Figure 69. Germany Small Nucleic Acid Therapies Market Size 2027-2032 ($ millions)
Figure 70. France Small Nucleic Acid Therapies Market Size 2027-2032 ($ millions)
Figure 71. UK Small Nucleic Acid Therapies Market Size 2027-2032 ($ millions)
Figure 72. Italy Small Nucleic Acid Therapies Market Size 2027-2032 ($ millions)
Figure 73. Russia Small Nucleic Acid Therapies Market Size 2027-2032 ($ millions)
Figure 74. Egypt Small Nucleic Acid Therapies Market Size 2027-2032 ($ millions)
Figure 75. South Africa Small Nucleic Acid Therapies Market Size 2027-2032 ($ millions)
Figure 76. Israel Small Nucleic Acid Therapies Market Size 2027-2032 ($ millions)
Figure 77. Turkey Small Nucleic Acid Therapies Market Size 2027-2032 ($ millions)
Figure 78. Global Small Nucleic Acid Therapies Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Small Nucleic Acid Therapies Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Small Nucleic Acid Therapies Market Size 2027-2032 ($ millions)
Figure 1. Small Nucleic Acid Therapies Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Small Nucleic Acid Therapies Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Small Nucleic Acid Therapies Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Small Nucleic Acid Therapies Sales Market Share by Country/Region (2025)
Figure 8. Small Nucleic Acid Therapies Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Small Nucleic Acid Therapies Market Size Market Share by Type in 2025
Figure 10. Small Nucleic Acid Therapies in Neuromuscular Diseases
Figure 11. Global Small Nucleic Acid Therapies Market: Neuromuscular Diseases (2021-2026) & ($ millions)
Figure 12. Small Nucleic Acid Therapies in hATTR
Figure 13. Global Small Nucleic Acid Therapies Market: hATTR (2021-2026) & ($ millions)
Figure 14. Small Nucleic Acid Therapies in COVID-19
Figure 15. Global Small Nucleic Acid Therapies Market: COVID-19 (2021-2026) & ($ millions)
Figure 16. Small Nucleic Acid Therapies in Other
Figure 17. Global Small Nucleic Acid Therapies Market: Other (2021-2026) & ($ millions)
Figure 18. Global Small Nucleic Acid Therapies Market Size Market Share by Application in 2025
Figure 19. Global Small Nucleic Acid Therapies Revenue Market Share by Player in 2025
Figure 20. Global Small Nucleic Acid Therapies Market Size Market Share by Region (2021-2026)
Figure 21. Americas Small Nucleic Acid Therapies Market Size 2021-2026 ($ millions)
Figure 22. APAC Small Nucleic Acid Therapies Market Size 2021-2026 ($ millions)
Figure 23. Europe Small Nucleic Acid Therapies Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Small Nucleic Acid Therapies Market Size 2021-2026 ($ millions)
Figure 25. Americas Small Nucleic Acid Therapies Value Market Share by Country in 2025
Figure 26. United States Small Nucleic Acid Therapies Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Small Nucleic Acid Therapies Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Small Nucleic Acid Therapies Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Small Nucleic Acid Therapies Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Small Nucleic Acid Therapies Market Size Market Share by Region in 2025
Figure 31. APAC Small Nucleic Acid Therapies Market Size Market Share by Type (2021-2026)
Figure 32. APAC Small Nucleic Acid Therapies Market Size Market Share by Application (2021-2026)
Figure 33. China Small Nucleic Acid Therapies Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Small Nucleic Acid Therapies Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Small Nucleic Acid Therapies Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Small Nucleic Acid Therapies Market Size Growth 2021-2026 ($ millions)
Figure 37. India Small Nucleic Acid Therapies Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Small Nucleic Acid Therapies Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Small Nucleic Acid Therapies Market Size Market Share by Country in 2025
Figure 40. Europe Small Nucleic Acid Therapies Market Size Market Share by Type (2021-2026)
Figure 41. Europe Small Nucleic Acid Therapies Market Size Market Share by Application (2021-2026)
Figure 42. Germany Small Nucleic Acid Therapies Market Size Growth 2021-2026 ($ millions)
Figure 43. France Small Nucleic Acid Therapies Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Small Nucleic Acid Therapies Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Small Nucleic Acid Therapies Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Small Nucleic Acid Therapies Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Small Nucleic Acid Therapies Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Small Nucleic Acid Therapies Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Small Nucleic Acid Therapies Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Small Nucleic Acid Therapies Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Small Nucleic Acid Therapies Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Small Nucleic Acid Therapies Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Small Nucleic Acid Therapies Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Small Nucleic Acid Therapies Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Small Nucleic Acid Therapies Market Size 2027-2032 ($ millions)
Figure 56. APAC Small Nucleic Acid Therapies Market Size 2027-2032 ($ millions)
Figure 57. Europe Small Nucleic Acid Therapies Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Small Nucleic Acid Therapies Market Size 2027-2032 ($ millions)
Figure 59. United States Small Nucleic Acid Therapies Market Size 2027-2032 ($ millions)
Figure 60. Canada Small Nucleic Acid Therapies Market Size 2027-2032 ($ millions)
Figure 61. Mexico Small Nucleic Acid Therapies Market Size 2027-2032 ($ millions)
Figure 62. Brazil Small Nucleic Acid Therapies Market Size 2027-2032 ($ millions)
Figure 63. China Small Nucleic Acid Therapies Market Size 2027-2032 ($ millions)
Figure 64. Japan Small Nucleic Acid Therapies Market Size 2027-2032 ($ millions)
Figure 65. Korea Small Nucleic Acid Therapies Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Small Nucleic Acid Therapies Market Size 2027-2032 ($ millions)
Figure 67. India Small Nucleic Acid Therapies Market Size 2027-2032 ($ millions)
Figure 68. Australia Small Nucleic Acid Therapies Market Size 2027-2032 ($ millions)
Figure 69. Germany Small Nucleic Acid Therapies Market Size 2027-2032 ($ millions)
Figure 70. France Small Nucleic Acid Therapies Market Size 2027-2032 ($ millions)
Figure 71. UK Small Nucleic Acid Therapies Market Size 2027-2032 ($ millions)
Figure 72. Italy Small Nucleic Acid Therapies Market Size 2027-2032 ($ millions)
Figure 73. Russia Small Nucleic Acid Therapies Market Size 2027-2032 ($ millions)
Figure 74. Egypt Small Nucleic Acid Therapies Market Size 2027-2032 ($ millions)
Figure 75. South Africa Small Nucleic Acid Therapies Market Size 2027-2032 ($ millions)
Figure 76. Israel Small Nucleic Acid Therapies Market Size 2027-2032 ($ millions)
Figure 77. Turkey Small Nucleic Acid Therapies Market Size 2027-2032 ($ millions)
Figure 78. Global Small Nucleic Acid Therapies Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Small Nucleic Acid Therapies Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Small Nucleic Acid Therapies Market Size 2027-2032 ($ millions)
